Salicylamide

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EM8BM710ZC. European Medicines Agency schedules Salicylamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10426MIG. Salicylamide generally arises in the molecular formula C7H7NO2. The term SALICYLAMIDE is an International Non-Proprietary Name or INN. SALICYLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule salicylamide under HS 29242995 and SITC 51479. As of Q4 2014, SALICYLAMIDE remains the US FDA Preferred Term for this commodity. Salicylamide bears US NLM identifiers UMLS ID C0036071 and NCI Concept Code C80566. SMILES: OC1C(CCCC1)C(=O)N.